Servotronics SVT 深 沪
等待开盘 10-10 09:30:00 美东时间
46.94
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 46.94
- 总市值 1.20亿
- 52周最高 47.48
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.6686
- 委 比 0.00%
- 总股本 255.65万
- 历史最高 47.48
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.77
- 每 手 1
- 风险率 12.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多依托欧盟教育资金，罗马尼亚高校与超图签署GIS软件采购合同
国际之路 近日，超图软件与罗马尼亚米哈伊一世国王生命科学大学（University of Life Sciences "King ...
09-24 11:45
XTI Aerospace Selects Garmin G700 TXi Avionics System for Revolutionary TriFan 600 Aircraft
Advanced Avionics for a Next-Generation Regional xVTOL Aircraft ENGLEWOOD, Colo., Aug. 21, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI"), a pioneer in xVTOL and powered-lif...
08-21 21:00
e.l.f. Beauty sees FQ1 profit erosion on tariffs, pulls FY26 guidance again
For a second consecutive quarter, e.l.f. Beauty’s (NYSE:ELF) quarterly results beat Wall Street’s expectations, but shares took a sharp turn lower as a tariff-related erosion in the company’s profits ...
08-07 05:55
Severn Trent Announces Internal Share Transfer by PDMR
The latest announcement is out from Severn Trent ( ($GB:SVT) ). Severn Trent Pl...
08-01 23:12
VivoPower cuts debt by $7.5M
VivoPower (NASDAQ:VVPR) has improved its balance sheet by $7.5 million through debt-for-equity swaps with select lenders and suppliers, and by issuing shares in lieu of certain directors' fees. All is...
07-22 20:52
Severn Trent Launches €12 Billion Euro Medium Term Note Programme
Severn Trent ( ($GB:SVT) ) has shared an announcement. Severn Trent Plc has ann...
07-17 17:32
Motorola Solutions initiated with bullish views at UBS
UBS began coverage of Motorola Solutions (NYSE:MSI) with a Buy rating and $490 price target. Shares of Motorola, which provides communications products and services, rose about 1% premarket on Wednesd...
07-16 21:30
Why Is Milestone Pharmaceuticals Stock Plunging On Friday?
FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support potential PSVT treatment launch.
07-12 00:22
Milestone says heart disorder therapy under FDA review again
Milestone Pharmaceuticals (NASDAQ:MIST) announced on Friday that the U.S. FDA accepted for review its responses to the rejection letter sent early this year regarding its marketing application for its...
07-11 19:34
Milestone Pharmaceuticals proposes capital raise via securities offering
Milestone Pharmaceuticals (NASDAQ:MIST) has launched a public offering to raise capital, that includes common shares, alongside both Series A and Series B warrants. For certain, investors will have th...
07-11 18:34
